Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

SELL
$82.84 - $88.09 $1,242 - $1,321
-15 Reduced 0.35%
4,214 $367,000
Q4 2023

Feb 07, 2024

SELL
$69.43 - $83.43 $66,375 - $79,759
-956 Reduced 18.44%
4,229 $348,000
Q3 2023

Oct 19, 2023

SELL
$78.22 - $90.4 $11,967 - $13,831
-153 Reduced 2.87%
5,185 $406,000
Q2 2023

Jul 17, 2023

BUY
$79.47 - $91.38 $8,344 - $9,594
105 Added 2.01%
5,338 $470,000
Q1 2023

May 04, 2023

BUY
$76.72 - $87.58 $9,896 - $11,297
129 Added 2.53%
5,233 $421,000
Q4 2022

Feb 01, 2023

BUY
$76.18 - $87.74 $16,302 - $18,776
214 Added 4.38%
5,104 $396,000
Q3 2022

Oct 24, 2022

SELL
$80.75 - $95.31 $2,907 - $3,431
-36 Reduced 0.73%
4,890 $394,000
Q2 2022

Jul 26, 2022

BUY
$87.4 - $113.09 $11,536 - $14,927
132 Added 2.75%
4,926 $442,000
Q1 2022

May 05, 2022

SELL
$100.58 - $112.38 $41,137 - $45,963
-409 Reduced 7.86%
4,794 $531,000
Q4 2021

Jan 26, 2022

BUY
$99.53 - $127.75 $13,934 - $17,885
140 Added 2.77%
5,203 $538,000
Q3 2021

Oct 21, 2021

BUY
$122.75 - $135.17 $8,960 - $9,867
73 Added 1.46%
5,063 $634,000
Q2 2021

Jul 26, 2021

BUY
$118.19 - $131.5 $22,574 - $25,116
191 Added 3.98%
4,990 $619,000
Q1 2021

May 04, 2021

SELL
$111.18 - $119.74 $7,782 - $8,381
-70 Reduced 1.44%
4,799 $566,000
Q4 2020

Jan 26, 2021

SELL
$100.57 - $117.14 $71,404 - $83,169
-710 Reduced 12.73%
4,869 $570,000
Q3 2020

Oct 19, 2020

BUY
$90.13 - $108.78 $46,687 - $56,348
518 Added 10.24%
5,579 $579,000
Q2 2020

Aug 04, 2020

SELL
$84.11 - $103.33 $224,153 - $275,374
-2,665 Reduced 34.49%
5,061 $464,000
Q1 2020

May 01, 2020

BUY
$72.92 - $121.3 $20,636 - $34,327
283 Added 3.8%
7,726 $696,000
Q4 2019

Feb 07, 2020

BUY
$104.49 - $114.54 $777,719 - $852,521
7,443 New
7,443 $844,000

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $115B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Great Diamond Partners, LLC Portfolio

Follow Great Diamond Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Diamond Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Great Diamond Partners, LLC with notifications on news.